Literature DB >> 8033760

Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms.

J E Rose1, F M Behm.   

Abstract

Previous studies have suggested that sensory cues associated with cigarette smoking can suppress certain smoking withdrawal symptoms, including craving for cigarettes. In this study we investigated the subjective effects of a cigarette substitute delivering a vapor of black pepper essential oil. Forty-eight cigarette smokers participated in a 3-h session conducted after overnight deprivation from smoking. Subjects were randomly assigned to one of three conditions: one group of smokers puffed on a device that delivered a vapor from essential oil of black pepper; a second group puffed on the device with a mint/menthol cartridge, and a third group used a device containing an empty cartridge. Subjects puffed and inhaled ad libitum from the device throughout the session during which no smoking was allowed. Reported craving for cigarettes was significantly reduced in the pepper condition relative to each of the two control conditions. In addition, negative affect and somatic symptoms of anxiety were alleviated in the pepper condition relative to the unflavored placebo. The intensity of sensations in the chest was also significantly higher for the pepper condition. These results support the view that respiratory tract sensations are important in alleviating smoking withdrawal symptoms. Cigarette substitutes delivering pepper constituents may prove useful in smoking cessation treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033760     DOI: 10.1016/0376-8716(94)90160-0

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

Review 1.  Aromatherapy: a systematic review.

Authors:  B Cooke; E Ernst
Journal:  Br J Gen Pract       Date:  2000-06       Impact factor: 5.386

2.  Effects of olfactory stimuli on urge reduction in smokers.

Authors:  M A Sayette; D J Parrott
Journal:  Exp Clin Psychopharmacol       Date:  1999-05       Impact factor: 3.157

3.  Skin conductance responses are elicited by the airway sensory effects of puffs from cigarettes.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Int J Psychophysiol       Date:  2006-01-05       Impact factor: 2.997

Review 4.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

Review 5.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

6.  Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.

Authors:  Julie K Staley; Suchitra Krishnan-Sarin; Kelly P Cosgrove; Erica Krantzler; Erin Frohlich; Edward Perry; Joel A Dubin; Kristina Estok; Eric Brenner; Ronald M Baldwin; Gilles D Tamagnan; John P Seibyl; Peter Jatlow; Marina R Picciotto; Edythe D London; Stephanie O'Malley; Christopher H van Dyck
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

7.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

Review 8.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

9.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Nicola Lindson; Chris Bullen; Rachna Begh; Annika Theodoulou; Caitlin Notley; Nancy A Rigotti; Tari Turner; Ailsa R Butler; Thomas R Fanshawe; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2021-04-29

Review 10.  Electronic cigarettes for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Hayden McRobbie; Chris Bullen; Rachna Begh; Lindsay F Stead; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.